We encourage you to sign up for the Lymphoma Program quarterly e-newsletter to receive announcements regarding new clinical trials, laboratory discoveries, approvals of new medications, and other advancements in lymphoma treatment and research. Use the form below to sign up. If you do not have an e-mail address, please provide a mailing address to receive a hard copy of the newsletter. You may unsubscribe at any time. We do not share our newsletter subscriber list with any other organization, nor do we sell the list to any marketing companies. If you have any questions about or suggestions for the newsletter, please call 212-746-2919 or email us.